NOVEL SULFONEUREA COMPOUNDS

The present invention relates to compounds of formula (I): wherein A, B, L, X, Y, R1, R2 and R4 are as defined in the specification. The present invention further relates to salts, solvates and prodrugs of such compounds, to pharmaceutical compositions comprising such compounds, and to the use of su...

Full description

Saved in:
Bibliographic Details
Main Authors SHANNON JONATHAN, THOM STEPHEN, CARRILLO ARREGUI JOKIN, ALANINE THOMAS
Format Patent
LanguageChinese
English
Published 11.05.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to compounds of formula (I): wherein A, B, L, X, Y, R1, R2 and R4 are as defined in the specification. The present invention further relates to salts, solvates and prodrugs of such compounds, to pharmaceutical compositions comprising such compounds, and to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by the inhibition of NLRP3. 本发明涉及式(I)的化合物:其中A、B、L、X、Y、R1、R2和R4如本说明书中所定义。本发明还涉及这类化合物的盐、溶剂合物和前药、包含这类化合物的药物组合物以及这类化合物尤其通过抑制NLRP3治疗和预防医学病症和疾病的用途。
Bibliography:Application Number: CN201980064997